Transforming acidic coiled-coil proteins (TACCs) in human cancer

Cancer Letters

Volumn 336, Issue 1, 2013, Pages 24-33

  Ha, Geun Hyoung ^a,b   Kim, Jung Lye ^a,b   Breuer, Eun Kyoung Yim ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Cancer; Centrosome; Microtubule; TACCs

Indexed keywords

ALP7 PROTEIN; D TRANSFORMING ACIDIC COILED COIL PROTEIN; MASKIN PROTEIN; MEMBRANE PROTEIN; TRANSFORMING ACIDIC COILED COIL 1 PROTEIN; TRANSFORMING ACIDIC COILED COIL 2 PROTEIN; TRANSFORMING ACIDIC COILED COIL 3 PROTEIN; TRANSFORMING ACIDIC COILED COIL PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

BLADDER CANCER; BREAST CANCER; CARCINOGENESIS; D TRANSFORMING ACIDIC COILED COIL GENE; DISEASE ASSOCIATION; DOWN REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GLIOBLASTOMA; HUMAN; LEUKEMIA; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MYELOMA; NONHUMAN; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SHORT SURVEY; TAC 1 GENE; UPREGULATION; UTERINE CERVIX CANCER;

EID: 84878974844     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.04.022     Document Type: Review

References (156)

1. Henderson C.G., Tucker J.B., Chaplin M.A., Mackie J.B., Maidment S.N., Mogensen M.M., Paton C.C. Reorganization of the centrosome and associated microtubules during the morphogenesis of a mouse cochlear epithelial cell. J. Cell Sci. 1994, 107(Pt 2):589-600.
2. Albee A.J., Wiese C. Xenopus TACC3/maskin is not required for microtubule stability but is required for anchoring microtubules at the centrosome. Mol. Biol. Cell 2008, 19:3347-3356.
3. Raff J.W. Centrosomes and cancer: lessons from a TACC. Trends Cell Biol. 2002, 12:222-225.
4. Tanaka K. Dynamic regulation of kinetochore-microtubule interaction during mitosis. J. Biochem. 2012, 152:415-424.
5. van der Vaart B., Akhmanova A., Straube A. Regulation of microtubule dynamic instability. Biochem. Soc. Trans. 2009, 37:1007-1013.
6. Pihan G.A., Purohit A., Wallace J., Knecht H., Woda B., Quesenberry P., Doxsey S.J. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 1998, 58:3974-3985.
7. Duensing S., Lee B.H., Dal Cin P., Munger K. Excessive centrosome abnormalities without ongoing numerical chromosome instability in a Burkitt's lymphoma. Mol. Cancer 2003, 2:30.
8. Trachana V., van Wely K.H., Guerrero A.A., Futterer A., Martinez A.C. Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability. Proc. Natl. Acad. Sci. USA 2007, 104:2691-2696.
9. Schuendeln M.M., Piekorz R.P., Wichmann C., Lee Y., McKinnon P.J., Boyd K., Takahashi Y., Ihle J.N. The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer. Mol. Cell Biol. 2004, 24:6403-6409.
10. Gergely F. Centrosomal TACCtics. Bioessays 2002, 24:915-925.
11. Schneider L., Essmann F., Kletke A., Rio P., Hanenberg H., Wetzel W., Schulze-Osthoff K., Nurnberg B., Piekorz R.P. The transforming acidic coiled coil 3 protein is essential for spindle-dependent chromosome alignment and mitotic survival. J. Biol. Chem. 2007, 282:29273-29283.
12. Gergely F., Karlsson C., Still I., Cowell J., Kilmartin J., Raff J.W. The TACC domain identifies a family of centrosomal proteins that can interact with microtubules. Proc. Natl. Acad. Sci. USA 2000, 97:14352-14357.
13. Sato M., Vardy L., Angel Garcia M., Koonrugsa N., Toda T. Interdependency of fission yeast Alp14/TOG and coiled coil protein Alp7 in microtubule localization and bipolar spindle formation. Mol. Biol. Cell 2004, 15:1609-1622.
14. Le Bot N., Tsai M.C., Andrews R.K., Ahringer J. TAC-1, a regulator of microtubule length in the C. elegans embryo. Curr. Biol. 2003, 13:1499-1505.
15. Gergely F., Kidd D., Jeffers K., Wakefield J.G., Raff J.W. D-TACC: a novel centrosomal protein required for normal spindle function in the early Drosophila embryo. EMBO J. 2000, 19:241-252.
16. O'Brien L.L., Albee A.J., Liu L., Tao W., Dobrzyn P., Lizarraga S.B., Wiese C. The Xenopus TACC homologue, maskin, functions in mitotic spindle assembly. Mol. Biol. Cell 2005, 16:2836-2847.
17. Still I.H., Hamilton M., Vince P., Wolfman A., Cowell J.K. Cloning of TACC1, an embryonically expressed, potentially transforming coiled coil containing gene, from the 8p11 breast cancer amplicon. Oncogene 1999, 18:4032-4038.
18. Lauffart B., Gangisetty O., Still I.H. Molecular cloning, genomic structure and interactions of the putative breast tumor suppressor TACC2. Genomics 2003, 81:192-201.
19. Still I.H., Vince P., Cowell J.K. The third member of the transforming acidic coiled coil-containing gene family, TACC3, maps in 4p16, close to translocation breakpoints in multiple myeloma, and is upregulated in various cancer cell lines. Genomics 1999, 58:165-170.
20. Steadman B.T., Schmidt P.H., Shanks R.A., Lapierre L.A., Goldenring J.R. Transforming acidic coiled-coil-containing protein 4 interacts with centrosomal AKAP350 and the mitotic spindle apparatus. J. Biol. Chem. 2002, 277:30165-30176.
21. Maxwell C.A., Keats J.J., Crainie M., Sun X., Yen T., Shibuya E., Hendzel M., Chan G., Pilarski L.M. RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. Mol. Biol. Cell 2003, 14:2262-2276.
22. Still I.H., Vettaikkorumakankauv A.K., DiMatteo A., Liang P. Structure-function evolution of the transforming acidic coiled coil genes revealed by analysis of phylogenetically diverse organisms. BMC Evol. Biol. 2004, 4:16.
23. Lauffart B., Sondarva G.V., Gangisetty O., Cincotta M., Still I.H. Interaction of TACC proteins with the FHL family: implications for ERK signaling. J. Cell Commun. Signal 2007, 1:5-15.
24. Vettaikkorumakankauv A., Gangisetty O., Cincotta M., Hawthorne L., Cowell J., Still I. The TACC proteins are coregulators of the rentinoid× Receptor b. Cancer Ther. 2008, 6:805-816.
25. Gangisetty O., Lauffart B., Sondarva G.V., Chelsea D.M., Still I.H. The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases. Oncogene 2004, 23:2559-2563.
26. Sadek C.M., Pelto-Huikko M., Tujague M., Steffensen K.R., Wennerholm M., Gustafsson J.A. TACC3 expression is tightly regulated during early differentiation. Gene Exp. Patterns 2003, 3:203-211.
27. Line A., Slucka Z., Stengrevics A., Li G., Rees R.C. Altered splicing pattern of TACC1 mRNA in gastric cancer. Cancer Genet. Cytogenet. 2002, 139:78-83.
28. Guyot R., Vincent S., Bertin J., Samarut J., Ravel-Chapuis P. The transforming acidic coiled coil (TACC1) protein modulates the transcriptional activity of the nuclear receptors TR and RAR. BMC Mol. Biol. 2010, 11:3.
29. Garcia M.A., Vardy L., Koonrugsa N., Toda T. Fission yeast ch-TOG/XMAP215 homologue Alp14 connects mitotic spindles with the kinetochore and is a component of the Mad2-dependent spindle checkpoint. EMBO J. 2001, 20:3389-3401.
30. Gergely F., Draviam V.M., Raff J.W. The ch-TOG/XMAP215 protein is essential for spindle pole organization in human somatic cells. Genes Dev. 2003, 17:336-341.
31. Zheng L., Schwartz C., Wee L., Oliferenko S. The fission yeast transforming acidic coiled coil-related protein Mia1p/Alp7p is required for formation and maintenance of persistent microtubule-organizing centers at the nuclear envelope. Mol. Biol. Cell 2006, 17:2212-2222.
32. Sato M., Koonrugsa N., Toda T., Vardy L., Tournier S., Millar J.B. Deletion of Mia1/Alp7 activates Mad2-dependent spindle assembly checkpoint in fission yeast. Nat. Cell Biol. 2003, 5:764-766. author reply 766.
33. Radcliffe P., Hirata D., Childs D., Vardy L., Toda T. Identification of novel temperature-sensitive lethal alleles in essential beta-tubulin and nonessential alpha 2-tubulin genes as fission yeast polarity mutants. Mol. Biol. Cell 1998, 9:1757-1771.
34. Zheng L., Schwartz C., Magidson V., Khodjakov A., Oliferenko S. The spindle pole bodies facilitate nuclear envelope division during closed mitosis in fission yeast. PLoS Biol. 2007, 5:e170.
35. Sato M., Okada N., Kakui Y., Yamamoto M., Yoshida M., Toda T. Nucleocytoplasmic transport of Alp7/TACC organizes spatiotemporal microtubule formation in fission yeast. EMBO Rep. 2009, 10:1161-1167.
36. Ling Y.C., Vjestica A., Oliferenko S. Nucleocytoplasmic shuttling of the TACC protein Mia1p/Alp7p is required for remodeling of microtubule arrays during the cell cycle. PLoS One 2009, 4:e6255.
37. Ohno M., Fornerod M., Mattaj I.W. Nucleocytoplasmic transport: the last 200 nanometers. Cell 1998, 92:327-336.
38. Sato M., Toda T. Alp7/TACC is a crucial target in Ran-GTPase-dependent spindle formation in fission yeast. Nature 2007, 447:334-337.
39. Bellanger J.M., Gonczy P. TAC-1 and ZYG-9 form a complex that promotes microtubule assembly in C. elegans embryos. Curr. Biol. 2003, 13:1488-1498.
40. Srayko M., Quintin S., Schwager A., Hyman A.A. Caenorhabditis elegans TAC-1 and ZYG-9 form a complex that is essential for long astral and spindle microtubules. Curr. Biol. 2003, 13:1506-1511.
41. Matthews L.R., Carter P., Thierry-Mieg D., Kemphues K. ZYG-9, a Caenorhabditis elegans protein required for microtubule organization and function, is a component of meiotic and mitotic spindle poles. J. Cell Biol. 1998, 141:1159-1168.
42. Bellanger J.M., Carter J.C., Phillips J.B., Canard C., Bowerman B., Gonczy P. ZYG-9, TAC-1 and ZYG-8 together ensure correct microtubule function throughout the cell cycle of C. elegans embryos. J. Cell Sci. 2007, 120:2963-2973.
43. Gonczy P., Bellanger J.M., Kirkham M., Pozniakowski A., Baumer K., Phillips J.B., Hyman A.A. Zyg-8, a gene required for spindle positioning in C. elegans, encodes a doublecortin-related kinase that promotes microtubule assembly. Dev. Cell 2001, 1:363-375.
44. Lee M.J., Gergely F., Jeffers K., Peak-Chew S.Y., Raff J.W. Msps/XMAP215 interacts with the centrosomal protein D-TACC to regulate microtubule behaviour. Nat. Cell Biol. 2001, 3:643-649.
45. Cheng S., Douglas-Jones A., Yang X., Mansel R.E., Jiang W.G. Transforming acidic coiled-coil-containing protein 2 (TACC2) in human breast cancer, expression pattern and clinical/prognostic relevance. Cancer Genomics Proteomics 2010, 7:67-73.
46. Giet R., McLean D., Descamps S., Lee M.J., Raff J.W., Prigent C., Glover D.M. Drosophila Aurora A kinase is required to localize D-TACC to centrosomes and to regulate astral microtubules. J. Cell Biol. 2002, 156:437-451.
47. Barros T.P., Kinoshita K., Hyman A.A., Raff J.W. Aurora A activates D-TACC-Msps complexes exclusively at centrosomes to stabilize centrosomal microtubules. J. Cell Biol. 2005, 170:1039-1046.
48. Cullen C.F., Ohkura H. Msps protein is localized to acentrosomal poles to ensure bipolarity of Drosophila meiotic spindles. Nat. Cell Biol. 2001, 3:637-642.
49. Stebbins-Boaz B., Cao Q., de Moor C.H., Mendez R., Richter J.D. Maskin is a CPEB-associated factor that transiently interacts with elF-4E. Mol. Cell 1999, 4:1017-1027.
50. Groisman I., Huang Y.S., Mendez R., Cao Q., Richter J.D. Translational control of embryonic cell division by CPEB and maskin. Cold Spring Harb. Symp. Quant. Biol. 2001, 66:345-351.
51. Conte N., Charafe-Jauffret E., Delaval B., Adelaide J., Ginestier C., Geneix J., Isnardon D., Jacquemier J., Birnbaum D. Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators. Oncogene 2002, 21:5619-5630.
52. Peset I., Seiler J., Sardon T., Bejarano L.A., Rybina S., Vernos I. Function and regulation of Maskin, a TACC family protein, in microtubule growth during mitosis. J. Cell Biol. 2005, 170:1057-1066.
53. Kinoshita K., Noetzel T.L., Pelletier L., Mechtler K., Drechsel D.N., Schwager A., Lee M., Raff J.W., Hyman A.A. Aurora A phosphorylation of TACC3/maskin is required for centrosome-dependent microtubule assembly in mitosis. J. Cell Biol. 2005, 170:1047-1055.
54. Groisman I., Huang Y.S., Mendez R., Cao Q., Theurkauf W., Richter J.D. CPEB, maskin, and cyclin B1 mRNA at the mitotic apparatus: implications for local translational control of cell division. Cell 2000, 103:435-447.
55. Albee A.J., Tao W., Wiese C. Phosphorylation of maskin by Aurora-A is regulated by RanGTP and importin beta. J. Biol. Chem. 2006, 281:38293-38301.
56. Pascreau G., Delcros J.G., Cremet J.Y., Prigent C., Arlot-Bonnemains Y. Phosphorylation of maskin by Aurora-A participates in the control of sequential protein synthesis during Xenopus laevis oocyte maturation. J. Biol. Chem. 2005, 280:13415-13423.
57. Sadek C.M., Jalaguier S., Feeney E.P., Aitola M., Damdimopoulos A.E., Pelto-Huikko M., Gustafsson J.A. Isolation and characterization of AINT: a novel ARNT interacting protein expressed during murine embryonic development. Mech. Dev. 2000, 97:13-26.
58. McKeveney P.J., Hodges V.M., Mullan R.N., Maxwell P., Simpson D., Thompson A., Winter P.C., Lappin T.R., Maxwell A.P. Characterization and localization of expression of an erythropoietin-induced gene, ERIC-1/TACC3, identified in erythroid precursor cells. Br. J. Haematol. 2001, 112:1016-1024.
59. Delaval B., Ferrand A., Conte N., Larroque C., Hernandez-Verdun D., Prigent C., Birnbaum D. Aurora B -TACC1 protein complex in cytokinesis. Oncogene 2004, 23:4516-4522.
60. Lauffart B., Howell S.J., Tasch J.E., Cowell J.K., Still I.H. Interaction of the transforming acidic coiled-coil 1 (TACC1) protein with ch-TOG and GAS41/NuBI1 suggests multiple TACC1-containing protein complexes in human cells. Biochem. J. 2002, 363:195-200.
61. Conte N., Delaval B., Ginestier C., Ferrand A., Isnardon D., Larroque C., Prigent C., Seraphin B., Jacquemier J., Birnbaum D. TACC1-chTOG-Aurora A protein complex in breast cancer. Oncogene 2003, 22:8102-8116.
62. Gabillard J.C., Ulisse S., Baldini E., Sorrenti S., Cremet J.Y., Coccaro C., Prigent C., D'Armiento M., Arlot-Bonnemains Y. Aurora-C interacts with and phosphorylates the transforming acidic coiled-coil 1 protein. Biochem. Biophys. Res. Commun. 2011, 408:647-653.
63. Tkacz I.D., Gupta S.K., Volkov V., Romano M., Haham T., Tulinski P., Lebenthal I., Michaeli S. Analysis of spliceosomal proteins in Trypanosomatids reveals novel functions in mRNA processing. J. Biol. Chem. 2010, 285:27982-27999.
64. Spittle C., Charrasse S., Larroque C., Cassimeris L. The interaction of TOGp with microtubules and tubulin. J. Biol. Chem. 2000, 275:20748-20753.
65. Fischer U., Heckel D., Michel A., Janka M., Hulsebos T., Meese E. Cloning of a novel transcription factor-like gene amplified in human glioma including astrocytoma grade I. Hum. Mol. Genet. 1997, 6:1817-1822.
66. Zimmermann K., Ahrens K., Matthes S., Buerstedde J.M., Stratling W.H., Phi-van L. Targeted disruption of the GAS41 gene encoding a putative transcription factor indicates that GAS41 is essential for cell viability. J. Biol. Chem. 2002, 277:18626-18631.
67. Hirose T., Kawabuchi M., Tamaru T., Okumura N., Nagai K., Okada M. Identification of tudor repeat associator with PCTAIRE 2 (Trap). A novel protein that interacts with the N-terminal domain of PCTAIRE 2 in rat brain. Eur. J. Biochem. 2000, 267:2113-2121.
68. Cully M., Shiu J., Piekorz R.P., Muller W.J., Done S.J., Mak T.W. Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis. Cancer Res. 2005, 65:10363-10370.
69. Chen H.M., Schmeichel K.L., Mian I.S., Lelievre S., Petersen O.W., Bissell M.J. AZU-1: a candidate breast tumor suppressor and biomarker for tumor progression. Mol. Biol. Cell 2000, 11:1357-1367.
70. Pu J.J., Li C., Rodriguez M., Banerjee D. Cloning and structural characterization of ECTACC, a new member of the transforming acidic coiled coil (TACC) gene family: cDNA sequence and expression analysis in human microvascular endothelial cells. Cytokine 2001, 13:129-137.
71. Peset I., Vernos I. The TACC proteins: TACC-ling microtubule dynamics and centrosome function. Trends Cell Biol. 2008, 18:379-388.
72. Takayama K., Horie-Inoue K., Suzuki T., Urano T., Ikeda K., Fujimura T., Takahashi S., Homma Y., Ouchi Y., Inoue S. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer. Mol. Endocrinol. 2012, 26:748-761.
73. Abu-Farha M., Lambert J.P., Al-Madhoun A.S., Elisma F., Skerjanc I.S., Figeys D. The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase. Mol. Cell Proteomics 2008, 7:560-572.
74. Dou Z., Ding X., Zereshki A., Zhang Y., Zhang J., Wang F., Sun J., Huang H., Yao X. TTK kinase is essential for the centrosomal localization of TACC2. FEBS Lett. 2004, 572:51-56.
75. Tien A.C., Lin M.H., Su L.J., Hong Y.R., Cheng T.S., Lee Y.C., Lin W.J., Still I.H., Huang C.Y. Identification of the substrates and interaction proteins of aurora kinases from a protein-protein interaction model. Mol. Cell Proteomics 2004, 3:93-104.
76. Tei S., Saitoh N., Funahara T., Iida S., Nakatsu Y., Kinoshita K., Kinoshita Y., Saya H., Nakao M. Simian virus 40 large T antigen targets the microtubule-stabilizing protein TACC2. J. Cell Sci. 2009, 122:3190-3198.
77. Harborth J., Weber K., Osborn M. GAS41, a highly conserved protein in eukaryotic nuclei, binds to NuMA. J. Biol. Chem. 2000, 275:31979-31985.
78. Debernardi S., Bassini A., Jones L.K., Chaplin T., Linder B., de Bruijn D.R., Meese E., Young B.D. The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex. Blood 2002, 99:275-281.
79. Carter K.C., Wang L., Shell B.K., Zamir I., Berger S.L., Moore P.A. The human transcriptional adaptor genes TADA2L and GCN5L2 colocalize to chromosome 17q12-q21 and display a similar tissue expression pattern. Genomics 1997, 40:497-500.
80. De Marchis L., Cropp C., Sheng Z.M., Bargo S., Callahan R. Candidate target genes for loss of heterozygosity on human chromosome 17q21. Br. J. Cancer 2004, 90:2384-2389.
81. Wong K., Zhang J., Awasthi S., Sharma A., Rogers L., Matlock E.F., Van Lint C., Karpova T., McNally J., Harrod R. Nerve growth factor receptor signaling induces histone acetyltransferase domain-dependent nuclear translocation of p300/CREB-binding protein-associated factor and hGCN5 acetyltransferases. J. Biol. Chem. 2004, 279:55667-55674.
82. Abu-Farha M., Lanouette S., Elisma F., Tremblay V., Butson J., Figeys D., Couture J.F. Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2. J. Mol. Cell Biol. 2011, 3:301-308.
83. Huang J., Perez-Burgos L., Placek B.J., Sengupta R., Richter M., Dorsey J.A., Kubicek S., Opravil S., Jenuwein T., Berger S.L. Repression of p53 activity by Smyd2-mediated methylation. Nature 2006, 444:629-632.
84. Brown M.A., Sims R.J., Gottlieb P.D., Tucker P.W. Identification and characterization of Smyd2: a split SET/MYND domain-containing histone H3 lysine 36-specific methyltransferase that interacts with the Sin3 histone deacetylase complex. Mol. Cancer 2006, 5:26.
85. Piekorz R.P., Hoffmeyer A., Duntsch C.D., McKay C., Nakajima H., Sexl V., Snyder L., Rehg J., Ihle J.N. The centrosomal protein TACC3 is essential for hematopoietic stem cell function and genetically interfaces with p53-regulated apoptosis. EMBO J. 2002, 21:653-664.
86. Garriga-Canut M., Orkin S.H. Transforming acidic coiled-coil protein 3 (TACC3) controls friend of GATA-1 (FOG-1) subcellular localization and regulates the association between GATA-1 and FOG-1 during hematopoiesis. J. Biol. Chem. 2004, 279:23597-23605.
87. Kewley R.J., Whitelaw M.L., Chapman-Smith A. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell Biol. 2004, 36:189-204.
88. Partch C.L., Gardner K.H. Coactivators necessary for transcriptional output of the hypoxia inducible factor, HIF, are directly recruited by ARNT PAS-B. Proc. Natl. Acad. Sci. USA 2011, 108:7739-7744.
89. Rylski M., Welch J.J., Chen Y.Y., Letting D.L., Diehl J.A., Chodosh L.A., Blobel G.A., Weiss M.J. GATA-1-mediated proliferation arrest during erythroid maturation. Mol. Cell Biol. 2003, 23:5031-5042.
90. Chlon T.M., Dore L.C., Crispino J.D. Cofactor-mediated restriction of GATA-1 chromatin occupancy coordinates lineage-specific gene expression. Mol. Cell 2012, 47:608-621.
91. Bargo S., Raafat A., McCurdy D., Amirjazil I., Shu Y., Traicoff J., Plant J., Vonderhaar B.K., Callahan R. Transforming acidic coiled-coil protein-3 (Tacc3) acts as a negative regulator of Notch signaling through binding to CDC10/Ankyrin repeats. Biochem. Biophys. Res. Commun. 2010, 400:606-612.
92. Angrisano T., Lembo F., Pero R., Natale F., Fusco A., Avvedimento V.E., Bruni C.B., Chiariotti L. TACC3 mediates the association of MBD2 with histone acetyltransferases and relieves transcriptional repression of methylated promoters. Nucl. Acids Res. 2006, 34:364-372.
93. Jung C.K., Jung J.H., Park G.S., Lee A., Kang C.S., Lee K.Y. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer. Pathol. Int. 2006, 56:503-509.
94. Hood F.E., Royle S.J. Pulling it together: the mitotic function of TACC3. Bioarchitecture 2011, 1:105-109.
95. Lauffart B., Gangisetty O., Still I.H. Evolutionary conserved interaction of TACC2/TACC3 with BARD1 and BRCA1: potential implications for DNA damage response in breast and ovarian cancer. Cancer Ther. 2007, 5:409-416.
96. Yao R., Natsume Y., Saiki Y., Shioya H., Takeuchi K., Yamori T., Toki H., Aoki I., Saga T., Noda T. Disruption of Tacc3 function leads to in vivo tumor regression. Oncogene 2012, 31:135-148.
97. Mori D., Yano Y., Toyo-oka K., Yoshida N., Yamada M., Muramatsu M., Zhang D., Saya H., Toyoshima Y.Y., Kinoshita K., Wynshaw-Boris A., Hirotsune S. NDEL1 phosphorylation by Aurora-A kinase is essential for centrosomal maturation, separation, and TACC3 recruitment. Mol. Cell Biol. 2007, 27:352-367.
98. Ulisse S., Baldini E., Toller M., Delcros J.G., Gueho A., Curcio F., De Antoni E., Giacomelli L., Ambesi-Impiombato F.S., Bocchini S., D'Armiento M., Arlot-Bonnemains Y. Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues. Endocr. Relat. Cancer 2007, 14:827-837.
99. Fielding A.B., Lim S., Montgomery K., Dobreva I., Dedhar S. A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells. Oncogene 2011, 30:521-534.
100. LeRoy P.J., Hunter J.J., Hoar K.M., Burke K.E., Shinde V., Ruan J., Bowman D., Galvin K., Ecsedy J.A. Localization of human TACC3 to mitotic spindles is mediated by phosphorylation on Ser558 by Aurora A: a novel pharmacodynamic method for measuring Aurora A activity. Cancer Res. 2007, 67:5362-5370.
101. Harrington E.A., Bebbington D., Moore J., Rasmussen R.K., Ajose-Adeogun A.O., Nakayama T., Graham J.A., Demur C., Hercend T., Diu-Hercend A., Su M., Golec J.M., Miller K.M. VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat. Med. 2004, 10:262-267.
102. Tyler R.K., Shpiro N., Marquez R., Eyers P.A. VX-680 inhibits Aurora A and Aurora B kinase activity in human cells. Cell Cycle 2007, 6:2846-2854.
103. Arlot-Bonnemains Y., Baldini E., Martin B., Delcros J.G., Toller M., Curcio F., Ambesi-Impiombato F.S., D'Armiento M., Ulisse S. Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines. Endocr. Relat. Cancer 2008, 15:559-568.
104. Fielding A.B., Dobreva I., McDonald P.C., Foster L.J., Dedhar S. Integrin-linked kinase localizes to the centrosome and regulates mitotic spindle organization. J. Cell Biol. 2008, 180:681-689.
105. Lin C.H., Hu C.K., Shih H.M. Clathrin heavy chain mediates TACC3 targeting to mitotic spindles to ensure spindle stability. J. Cell Biol. 2010, 189:1097-1105.
106. Jeng J.C., Lin Y.M., Lin C.H., Shih H.M. Cdh1 controls the stability of TACC3. Cell Cycle 2009, 8:3529-3536.
107. Gomez-Baldo L., Schmidt S., Maxwell C.A., Bonifaci N., Gabaldon T., Vidalain P.O., Senapedis W., Kletke A., Rosing M., Barnekow A., Rottapel R., Capella G., Vidal M., Astrinidis A., Piekorz R.P., Pujana M.A. TACC3-TSC2 maintains nuclear envelope structure and controls cell division. Cell Cycle 2010, 9:1143-1155.
108. Ha G.H., Park J.S., Breuer E.K. TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. Cancer Lett. 2013.
109. Devilard E., Bladou F., Ramuz O., Karsenty G., Dales J.P., Gravis G., Nguyen C., Bertucci F., Xerri L., Birnbaum D. FGFR1 and WT1 are markers of human prostate cancer progression. BMC Cancer 2006, 6:272.
110. Lauffart B., Vaughan M.M., Eddy R., Chervinsky D., DiCioccio R.A., Black J.D., Still I.H. Aberrations of TACC1 and TACC3 are associated with ovarian cancer. BMC Womens Health 2005, 5:8.
111. Line A., Stengrevics A., Slucka Z., Li G., Jankevics E., Rees R.C. Serological identification and expression analysis of gastric cancer-associated genes. Br. J. Cancer 2002, 86:1824-1830.
112. Partheen K., Levan K., Osterberg L., Horvath G. Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors. Eur. J. Cancer 2006, 42:2846-2854.
113. Richard F., Pacyna-Gengelbach M., Schluns K., Fleige B., Winzer K.J., Szymas J., Dietel M., Petersen I., Schwendel A. Patterns of chromosomal imbalances in invasive breast cancer. Int. J. Cancer 2000, 89:305-310.
114. Ichimura K., Schmidt E.E., Miyakawa A., Goike H.M., Collins V.P. Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes, Chromosomes Cancer 1998, 22:9-15.
115. Girard L., Zochbauer-Muller S., Virmani A.K., Gazdar A.F., Minna J.D. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 2000, 60:4894-4906.
116. Steck P.A., Lin H., Langford L.A., Jasser S.A., Koul D., Yung W.K., Pershouse M.A. Functional and molecular analyses of 10q deletions in human gliomas. Genes, Chromosomes Cancer 1999, 24:135-143.
117. Leube B., Drechsler M., Muhlmann K., Schafer R., Schulz W.A., Santourlidis S., Anastasiadis A., Ackermann R., Visakorpi T., Muller W., Royer-Pokora B. Refined mapping of allele loss at chromosome 10q23-26 in prostate cancer. Prostate 2002, 50:135-144.
118. Nagase S., Sato S., Tezuka F., Wada Y., Yajima A., Horii A. Deletion mapping on chromosome 10q25-q26 in human endometrial cancer. Br. J. Cancer 1996, 74:1979-1983.
119. Duncan C.G., Killela P.J., Payne C.A., Lampson B., Chen W.C., Liu J., Solomon D., Waldman T., Towers A.J., Gregory S.G., McDonald K.L., McLendon R.E., Bigner D.D., Yan H. Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes. Oncotarget 2010, 1:265-277.
120. Kiemeney L.A., Sulem P., Besenbacher S., Vermeulen S.H., Sigurdsson A., Thorleifsson G., Gudbjartsson D.F., Stacey S.N., Gudmundsson J., Zanon C., Kostic J., Masson G., Bjarnason H., Palsson S.T., Skarphedinsson O.B., Gudjonsson S.A., Witjes J.A., Grotenhuis A.J., Verhaegh G.W., Bishop D.T., Sak S.C., Choudhury A., Elliott F., Barrett J.H., Hurst C.D., de Verdier P.J., Ryk C., Rudnai P., Gurzau E., Koppova K., Vineis P., Polidoro S., Guarrera S., Sacerdote C., Campagna M., Placidi D., Arici C., Zeegers M.P., Kellen E., Gutierrez B.S., Sanz-Velez J.I., Sanchez-Zalabardo M., Valdivia G., Garcia-Prats M.D., Hengstler J.G., Blaszkewicz M., Dietrich H., Ophoff R.A., van den Berg L.H., Alexiusdottir K., Kristjansson K., Geirsson G., Nikulasson S., Petursdottir V., Kong A., Thorgeirsson T., Mungan N.A., Lindblom A., van Es M.A., Porru S., Buntinx F., Golka K., Mayordomo J.I., Kumar R., Matullo G., Steineck G., Kiltie A.E., Aben K.K., Jonsson E., Thorsteinsdottir U., Knowles M.A., Rafnar T., Stefansson K. A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer. Nat. Genet. 2010, 42:415-419.
121. Malgeri U., Baldini L., Perfetti V., Fabris S., Vignarelli M.C., Colombo G., Lotti V., Compasso S., Bogni S., Lombardi L., Maiolo A.T., Neri A. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts. Cancer Res. 2000, 60:4058-4061.
122. Wang M., Chu H., Yan F., Qin C., Li P., Yuan L., Yin C., Xu J., Zhang Z. Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population. Carcinogenesis 2011, 32:872-875.
123. Gusella J.F., Wexler N.S., Conneally P.M., Naylor S.L., Anderson M.A., Tanzi R.E., Watkins P.C., Ottina K., Wallace M.R., Sakaguchi A.Y., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983, 306:234-238.
124. Chin K., DeVries S., Fridlyand J., Spellman P.T., Roydasgupta R., Kuo W.L., Lapuk A., Neve R.M., Qian Z., Ryder T., Chen F., Feiler H., Tokuyasu T., Kingsley C., Dairkee S., Meng Z., Chew K., Pinkel D., Jain A., Ljung B.M., Esserman L., Albertson D.G., Waldman F.M., Gray J.W. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006, 10:529-541.
125. Vendrell J.A., Magnino F., Danis E., Duchesne M.J., Pinloche S., Pons M., Birnbaum D., Nguyen C., Theillet C., Cohen P.A. Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation. J. Mol. Endocrinol. 2004, 32:397-414.
126. Ghayad S.E., Vendrell J.A., Bieche I., Spyratos F., Dumontet C., Treilleux I., Lidereau R., Cohen P.A. Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer. J. Mol. Endocrinol. 2009, 42:87-103.
127. Ma X.J., Salunga R., Tuggle J.T., Gaudet J., Enright E., McQuary P., Payette T., Pistone M., Stecker K., Zhang B.M., Zhou Y.X., Varnholt H., Smith B., Gadd M., Chatfield E., Kessler J., Baer T.M., Erlander M.G., Sgroi D.C. Gene expression profiles of human breast cancer progression. Proc. Natl. Acad. Sci. USA 2003, 100:5974-5979.
128. Partheen K., Levan K., Osterberg L., Claesson I., Fallenius G., Sundfeldt K., Horvath G. Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas. Int. J. Cancer 2008, 123:2130-2137.
129. Peters D.G., Kudla D.M., Deloia J.A., Chu T.J., Fairfull L., Edwards R.P., Ferrell R.E. Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1717-1723.
130. L'Esperance S., Popa I., Bachvarova M., Plante M., Patten N., Wu L., Tetu B., Bachvarov D. Gene expression profiling of paired ovarian tumors obtained prior to and following adjuvant chemotherapy: molecular signatures of chemoresistant tumors. Int. J. Oncol. 2006, 29:5-24.
131. Yim E.K., Tong S.Y., Ho E.M., Bae J.H., Um S.J., Park J.S. Anticancer effects on TACC3 by treatment of paclitaxel in HPV-18 positive cervical carcinoma cells. Oncol. Rep. 2009, 21:549-557.
132. Parsons D.W. The evolving picture of the glioblastoma genome. Oncotarget 2010, 1:237-238.
133. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., Mankoo P., Carter H., Siu I.M., Gallia G.L., Olivi A., McLendon R., Rasheed B.A., Keir S., Nikolskaya T., Nikolsky Y., Busam D.A., Tekleab H., Diaz L.A., Hartigan J., Smith D.R., Strausberg R.L., Marie S.K., Shinjo S.M., Yan H., Riggins G.J., Bigner D.D., Karchin R., Papadopoulos N., Parmigiani G., Vogelstein B., Velculescu V.E., Kinzler K.W. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812.
134. Singh D., Chan J.M., Zoppoli P., Niola F., Sullivan R., Castano A., Liu E.M., Reichel J., Porrati P., Pellegatta S., Qiu K., Gao Z., Ceccarelli M., Riccardi R., Brat D.J., Guha A., Aldape K., Golfinos J.G., Zagzag D., Mikkelsen T., Finocchiaro G., Lasorella A., Rabadan R., Iavarone A. Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma. Science 2012, 337:1231-1235.
135. Williams S.V., Hurst C.D., Knowles M.A. Oncogenic FGFR3 gene fusions in bladder cancer. Hum. Mol. Genet. 2012, 22:795-803.
136. Kang H., Wilson C.S., Harvey R.C., Chen I.M., Murphy M.H., Atlas S.R., Bedrick E.J., Devidas M., Carroll A.J., Robinson B.W., Stam R.W., Valsecchi M.G., Pieters R., Heerema N.A., Hilden J.M., Felix C.A., Reaman G.H., Camitta B., Winick N., Carroll W.L., Dreyer Z.E., Hunger S.P., Willman C.L. Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood 2012, 119:1872-1881.
137. Chakraborty J., Okonta H., Bagalb H., Lee S.J., Fink B., Changanamkandat R., Duggan J. Retroviral gene insertion in breast milk mediated lymphomagenesis. Virology 2008, 377:100-109.
138. Fan H. Leukemogenesis by Moloney murine leukemia virus: a multistep process. Trends Microbiol. 1997, 5:74-82.
139. Keats J.J., Reiman T., Maxwell C.A., Taylor B.J., Larratt L.M., Mant M.J., Belch A.R., Pilarski L.M. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood 2003, 101:1520-1529.
140. Moreau P., Facon T., Leleu X., Morineau N., Huyghe P., Harousseau J.L., Bataille R., Avet-Loiseau H., Intergroupe Francophone du M. Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy. Blood 2002, 100:1579-1583.
141. Stewart J.P., Thompson A., Santra M., Barlogie B., Lappin T.R., Shaughnessy J. Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma. Br. J. Haematol. 2004, 126:72-76.
142. Hodis E., Watson I.R., Kryukov G.V., Arold S.T., Imielinski M., Theurillat J.P., Nickerson E., Auclair D., Li L., Place C., Dicara D., Ramos A.H., Lawrence M.S., Cibulskis K., Sivachenko A., Voet D., Saksena G., Stransky N., Onofrio R.C., Winckler W., Ardlie K., Wagle N., Wargo J., Chong K., Morton D.L., Stemke-Hale K., Chen G., Noble M., Meyerson M., Ladbury J.E., Davies M.A., Gershenwald J.E., Wagner S.N., Hoon D.S., Schadendorf D., Lander E.S., Gabriel S.B., Getz G., Garraway L.A., Chin L. A landscape of driver mutations in melanoma. Cell 2012, 150:251-263.
143. Bignold L.P., Coghlan B.L., Jersmann H.P. Cancer morphology, carcinogenesis and genetic instability: a background. EXS 2006, 1-24.
144. Deng C.X. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucl. Acids Res. 2006, 34:1416-1426.
145. Mostoslavsky R., Chua K.F., Lombard D.B., Pang W.W., Fischer M.R., Gellon L., Liu P., Mostoslavsky G., Franco S., Murphy M.M., Mills K.D., Patel P., Hsu J.T., Hong A.L., Ford E., Cheng H.L., Kennedy C., Nunez N., Bronson R., Frendewey D., Auerbach W., Valenzuela D., Karow M., Hottiger M.O., Hursting S., Barrett J.C., Guarente L., Mulligan R., Demple B., Yancopoulos G.D., Alt F.W. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006, 124:315-329.
146. Jakubczak J.L., Merlino G., French J.E., Muller W.J., Paul B., Adhya S., Garges S. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc. Natl. Acad. Sci. USA 1996, 93:9073-9078.
147. Moore J.L., Rush L.M., Breneman C., Mohideen M.A., Cheng K.C. Zebrafish genomic instability mutants and cancer susceptibility. Genetics 2006, 174:585-600.
148. Negrini S., Gorgoulis V.G., Halazonetis T.D. Genomic instability-an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 2010, 11:220-228.
149. Kramer A., Neben K., Ho A.D. Centrosome replication, genomic instability and cancer. Leukemia 2002, 16:767-775.
150. Ikezoe T., Yang J., Nishioka C., Tasaka T., Taniguchi A., Kuwayama Y., Komatsu N., Bandobashi K., Togitani K., Koeffler H.P., Taguchi H. A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia. Mol. Cancer Ther. 2007, 6:1851-1857.
151. Carpinelli P., Moll J. Is there a future for Aurora kinase inhibitors for anticancer therapy?. Curr. Opin. Drug Discov. Devel. 2009, 12:533-542.
152. Schneider L., Essmann F., Kletke A., Rio P., Hanenberg H., Schulze-Osthoff K., Nurnberg B., Piekorz R.P. TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF mediated cell cycle arrest. Oncogene 2008, 27:116-125.
153. Schmidt S., Schneider L., Essmann F., Cirstea I.C., Kuck F., Kletke A., Janicke R.U., Wiek C., Hanenberg H., Ahmadian M.R., Schulze-Osthoff K., Nurnberg B., Piekorz R.P. The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program. Oncogene 2010, 29:6184-6192.
154. Ha G.H., Breuer E.K. Mitotic Kinases and p53 Signaling. Biochem. Res. Int. 2012, 2012:195903.
155. Chan K.S., Koh C.G., Li H.Y. Mitosis-targeted anti-cancer therapies: where they stand. Cell Death. Dis. 2012, 3:e411.
156. Trivedi S. Repeats in transforming acidic coiled-coil (TACC) genes. Biochem. Genet. 2013.